The largest database of trusted experimental protocols

Cd 1 male nude nu nu mice

Manufactured by Charles River Laboratories
Sourced in Italy

The CD-1 male nude (nu/nu) mice are an immunodeficient mouse model. They are characterized by a lack of thymus-derived (T) lymphocytes due to a genetic mutation, resulting in a severely compromised immune system.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using cd 1 male nude nu nu mice

1

Xenograft Tumor Growth Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD-1 male nude (nu/nu) mice (5 weeks old and weighing 26–28 g) were purchased from Charles River Laboratories (Calco, Italy).
Nude mice were injected into the hind leg muscles with 5 × 105 shSCR, shTRF2, shSULF2 or shTRF2+SULF2 HCT116 cells/mouse. Tumors were measured in two dimensions using a caliper at the indicated time points and tumor weight was calculated using the formula: a × b2/2, where a and b are the long and short sizes of the tumor, respectively. Each experimental group included five mice.
+ Open protocol
+ Expand
2

Intracardiac Metastasis Modeling in Nude Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD-1 male nude (nu/nu) mice, 6–8 weeks old and weighing 22-24 g were purchased from Charles River Laboratories (Calco, Italy). The procedures involving mice were in compliance with Regina Elena National Cancer Institute animal care guidelines and with national and international directives (D.L. March 4, 2014, no. 26; directive 2010/63/EU of the European parliament and of the council; Guide for the Care and Use of Laboratory Animals, United States National Research Council, 2011).
For the intracardiac experimental metastasis model, nude mice (age 8–10 weeks) were anesthetized and injected with 2×106 cells of NRASQ61L (2/14, 2/17) or BRAFV600E (2/21, 2/33) clones, suspended in 100 μl sterile PBS, into the left ventricle of the heart by nonsurgical means. The spontaneous, pulsatile entrance of bright red oxygenated blood into the transparent needle hub indicated proper positioning of the needle. After 5 weeks, the mice were sacrificed; selected organs were excised from the mice at necropsy and were preserved in 10% formalin solution for subsequent scoring of metastasis. NRASQ61L (2/14, 2/17) and NRAS/Sema6A cells (2/14, and 2/17) were injected intracardially as above described, and after 7 weeks the mice were sacrificed and the organs were processed and analyzed as described above. Box plot of in vivo metastasis analysis was obtained by software Prism version 6.0.
+ Open protocol
+ Expand
3

Evaluation of Tumorigenic Ability in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six- to eight-week-old CD-1 male nude (nu/nu) mice weighing 22–24 g were purchased from Charles River Laboratories (Calco, Italy). The procedures involving mouse care were in compliance with the Regina Elena National Cancer Institute animal care guidelines and with international directives (directive 2010/63/EU of the European parliament and council; Guide for the Care and Use of Laboratory Animals, United States National Research Council, 2011). To evaluate the tumorigenic ability of LMNA-KD cells or sphere-derived adherent cells, the mice were injected subcutaneously into the left flank with various concentrations of cells (from 5 × 104 to 1 × 107 cells/mouse) in 200 μl of Matrigel (BD Biosciences-Discovery Labware). Each group included five mice. Tumor sizes were measured three times a week in two dimensions using a caliper, and tumor weight was calculated using the following formula: a × b2/2, where a and b are the long and short diameters of the tumor, respectively.
+ Open protocol
+ Expand
4

Antitumor Activity of Enzalutamide and 14d in Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old CD-1 male nude (nu/nu) mice (Charles River Laboratories, Calco, Italy) were used. Experiments were carried out at the Animal Facility of Fondazione IRCCS Istituto Nazionale dei Tumori of Milan, Italy. The procedures were in compliance with our institutional animal care guidelines and with international directives in accordance with Italian law and approval by the Ministry of Health. The animals were euthanized by cervical dislocation when tumors reached a mean volume of 800 mm3. For antitumor activity experiments, CW22Rv1 prostate cancer cells (5 × 106 cells/mouse in 100 μL of saline) were subcutaneously injected in the right flank of the mice. Animals were randomized, divided into groups (5 mice per group), and starting the day after cell injection, treated orally by gavage with 50 mg/kg of enzalutamide or 14d at a volume of 10 mL/kg of body weight, every day for 5 days a week for 3 weeks (qdx5/wx3w). All the compounds were dissolved in DMSO and Cremophor and suspended in PBS (10% + 5% + 85%). Control mice were treated with vehicle for the same treatment period. Tumor size was measured by caliper, and tumor volume was calculated using the following formula: a × b2/2, where a and b are the long and short diameters of the tumor, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!